In the high-risk group, even though we found that low PSA concentrations are associated with poor prognosis for all T stages, the hazard ratio for low PSA concentrations in patients with T4 prostate cancer was significantly higher than for the other T stages. This evidence concerns the gene KLK3 and prostate cancer.